Valo Therapeutics Oy
2768695-4ActiveDeveloping novel peptide-coated oncolytic virus immunotherapies for cancer.
Översikt
- Okänt
- Anställda
- Okänt
- Omsättning
- 2016
- Grundat
Nyckelbeslutsfattare
Malcolm K. Brenner
Member of the Scientific and Clinical Advisory Board
Lukasz Kuryk
VP Translational and Clinical Science, IP Manager
Andrew Dean
Member of the Board
Jeffrey Bockman
Member of the Scientific and Clinical Advisory Board
+17 fler kontakter i Funnelfeedr
Beskrivning
Valo Therapeutics (ValoTx) is a biotechnology company spun out from the University of Helsinki, specializing in cancer immunotherapy. The organization focuses on developing novel treatments by uniquely combining oncolytic virus therapy, peptide vaccination, and viral vector approaches. Their core pr...
Taggar
Nyckelord
Företagsinformation
- Bransch
- Okänt
- Juridisk form
- 16
- Momsnummer
- FI27686954
Beslutsfattare
21 kontakter i FunnelfeedrMalcolm K. Brenner
Member of the Scientific and Clinical Advisory Board
Lukasz Kuryk
VP Translational and Clinical Science, IP Manager
Andrew Dean
Member of the Board
Jeffrey Bockman
Member of the Scientific and Clinical Advisory Board
Harri Jarvelainen
Chief Operating Officer
Otto Kari
VP, Head of Antigen Business Unit
Vincenzo Cerullo
Chairman of the Valo Tx Scientific and Clinical Advisory Board
Marcella Origgi
CEO
Paolo Antonio Ascierto
Member of the Scientific and Clinical Advisory Board
Kevin Harrington
Member of the Scientific and Clinical Advisory Board
Leena Ylösmäki
VP Preclinical Development
Sari Pesonen
CSO
Petri Priha
VP of CMC
Paul Porter
Member of the Board
Philip Stanecki
Financial Controller
Matthew Vaughan
Business Operations Director
Hanne Cojoc
QA Manager / Technical Scientist
Övriga kontakter
Joseph Ndika
Senior Scientist, Antigen Analytics
Suvi Karumo
Laboratory Scientist, Antigen Business Unit
Kalle Manninen
Technical Scientist
Sandeep Kumar
Research Scientist II
Liknande företag
20 liknande företag i FunnelfeedrSolid Immuno-Oncology Oy
Developing organ-on-chip technology for advanced cancer treatment decisions.
Sox Therapeutics AB
1–4 anställdaDeveloping targeted AAV gene therapies for malignant brain tumors.
AAX Biotech AB
5–9 anställdaResearch-driven biotech advancing antibody therapies via proprietary technology.
Nanohumps Biosciences Oy
Pioneering revolutionary cancer therapies using proprietary nanosized antibodies.
Oncotech Nordic AB
0 anställdaDeveloping AI diagnostics and immunotherapy to conquer global cancer.
Utforska mer
Frågor om Valo Therapeutics Oy
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo